0000905718-14-000315.txt : 20140529
0000905718-14-000315.hdr.sgml : 20140529
20140529174748
ACCESSION NUMBER: 0000905718-14-000315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140529
FILED AS OF DATE: 20140529
DATE AS OF CHANGE: 20140529
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001261249
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 101 POOR FARM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540-1715
BUSINESS PHONE: 609-683-1880
MAIL ADDRESS:
STREET 1: 101 POOR FARM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540-1715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INVESTOR AB
CENTRAL INDEX KEY: 0000889232
STATE OF INCORPORATION: V7
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36464
FILM NUMBER: 14877268
BUSINESS ADDRESS:
STREET 1: ARSENALSGATAN 8C
STREET 2: SE-103 32
CITY: STOCKHOLM
STATE: V7
ZIP: 00000
BUSINESS PHONE: 46-8-6142000
MAIL ADDRESS:
STREET 1: ARSENALSGATAN 8C
STREET 2: SE-103 32
CITY: STOCKHOLM
STATE: V7
ZIP: 00000
4
1
agile_form4may292014.xml
OWNERSHIP DOCUMENT
X0306
4
2014-05-29
0
0001261249
AGILE THERAPEUTICS INC
AGRX
0000889232
INVESTOR AB
C/O INVESTOR GROWTH CAPITAL, LLC
ONE ROCKEFELLER PLAZA, SUITE 2801
NEW YORK
NY
10020
0
0
1
0
Common Stock, par value $0.0001 per share
2014-05-29
4
P
0
2509949
6.00
A
3509949
I
See Footnotes
As of May 29, 2014 (the "Filing Date"), certain affiliated entities of Investor AB, a publicly held Swedish company (the "Reporting Person"), hold 3,509,949 shares of common stock, $0.0001 par value per share (the "Common Shares"), of Agile Therapeutics, Inc., a Delaware corporation (the "Company"). The Reporting Person, through one or more intermediate entities, previously held certain convertible securities which were automatically converted into 2,509,949 Common Shares upon the closing of the Company's initial public offering. As a result of the foregoing, the Reporting Person, through one or more intermediate entities, possesses the sole power to vote and the sole power to direct the disposition of the Common Shares reported herein. Accordingly, the Reporting Person, as of the Filing Date, may be deemed to beneficially own 3,509,949 Common Shares.
The Reporting Person interest in the Common Shares reported herein is limited to its pecuniary interest, if any, in such Common Shares.
Investor AB /s/ Michael V. Oporto, Authorized Signatory
2014-05-29